Kangrin And Boqe Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Thane, Maharashtra, India, established in 2003.
2003 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Kangrin And Boqe Pharmaceutical Private Limited

Kangrin And Boqe Pharmaceutical Private Limited, a active private limited company, was established on 28 November 2003 in Thane, Maharashtra, India. Engaging in api manufacturers within the trade sector, it holds CIN: U24231MH2003PTC143320. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Ashish Shrimanth Ghosh (Director), Nilesh Pravin Lokhande (Additional Director). Past directors included Sambhu Nath Paul, Pradip Kumar Pal, Sudip Paul. It holds ₹4.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 212 Blossom Chsraheja Complex Kalyan West, Thane, Maharashtra.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231MH2003PTC143320

  • Registration Number

    143320

  • Incorporation Date

    28 November 2003

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 22 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 4.00 Cr
  • Revenue Growth **** -29.28%
  • Profit Growth **** -22.39%
  • Ebitda **** -19.26%
  • Net Worth 262.56%
  • Total Assets -61.23%
Company report

Kangrin And Boqe Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kangrin And Boqe Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Kangrin And Boqe Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Ashish Shrimanth Ghosh Director 25 Jan 2021 Current
Nilesh Pravin Lokhande Additional Director 20 May 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 10 Mar 2019 Past
Pramod Abcsdd Director 04 Apr 2019 Past
Pramod Abcsdd Director 20 May 2025 Past
Pramod Abcsdd Director 04 Apr 2019 Past
Pramod Abcsdd Director 01 Feb 2023 Past
Pramod Abcsdd Director 04 Apr 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kangrin And Boqe Pharmaceutical.

Logus Labortries Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 29.28% decrease. The company also saw a substantial fall in profitability, with a 22.39% decrease in profit. The company's net worth Soared by an impressive increase of 262.56%.

Kangrin And Boqe Pharmaceutical revenue growth over time
Kangrin And Boqe Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -29.28%
*******
*******
*******
*******
Revenue from Operations
*******
 -29.28%
*******
*******
*******
*******
Total Assets
*******
 -61.23%
*******
*******
*******
*******
Profit or Loss
*******
 -22.39%
*******
*******
*******
*******
Net Worth
*******
 262.56%
*******
*******
*******
*******
EBITDA
*******
 -19.26%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kangrin And Boqe Pharmaceutical?

Unlock access to Kangrin And Boqe Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹40,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 4.00 Cr
Latest Charge Details
Date Lender Amount Status
20 Jun 2025 Canara Bank ₹4.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Kangrin And Boqe Pharmaceutical?

Unlock and access historical data on people associated with Kangrin And Boqe Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kangrin And Boqe Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kangrin And Boqe Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kangrin And Boqe Pharmaceutical
Recent Activity within the Organization
  • Charges

    A charge with Canara Bank amounted to Rs. 40.00 M with Charge ID 101139261 was registered on 20 Jun 2025. was recorded as a recent event.

  • Director Appointment

    The activity Nilesh Pravin Lokhande was appointed as a Additional Director was appointed as a Additional Director on 20 May 2025 & has been associated with this company since 8 months 21 days . was completed.

  • Annual General Meeting

    The activity Kangrin And Boqe Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Kangrin And Boqe Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Ashish Shrimanth Ghosh was appointed as a Director was appointed as a Director on 25 Jan 2021 & has been associated with this company since 5 years 14 days . was recorded as a recent event.

  • Company Incorporation

    Progress on Kangrin And Boqe Pharmaceutical Private Limited was registered on 28 Nov 2003 with Roc Mumbai & aged 22 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kangrin And Boqe Pharmaceutical Private Limited?

The CIN of Kangrin And Boqe Pharmaceutical Private Limited is U24231MH2003PTC143320.

Where is Kangrin And Boqe Pharmaceutical Private Limited headquartered?

Kangrin And Boqe Pharmaceutical Private Limited is headquartered at 212 Blossom Chsraheja Complex Kalyan West, Thane, Maharashtra.

When was Kangrin And Boqe Pharmaceutical Private Limited incorporated?

Kangrin And Boqe Pharmaceutical Private Limited was incorporated on 28 November 2003.

Who are the current directors of Kangrin And Boqe Pharmaceutical Private Limited?

The current directors of Kangrin And Boqe Pharmaceutical Private Limited are

What is the primary industry of Kangrin And Boqe Pharmaceutical Private Limited?

The primary industry of Kangrin And Boqe Pharmaceutical Private Limited is Trade.

Is Kangrin And Boqe Pharmaceutical Private Limited a listed company?

Kangrin And Boqe Pharmaceutical Private Limited is unlisted.

What is the capital structure of Kangrin And Boqe Pharmaceutical Private Limited?

The authorized capital of Kangrin And Boqe Pharmaceutical Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Kangrin And Boqe Pharmaceutical Private Limited?

The compliance status of Kangrin And Boqe Pharmaceutical Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available